Several countries in Europe have suspended the use of the Coronavirus vaccine developed by the University of AstraZeneca / Oxford because of concerns about blood clots, despite claims by the World Health Organization (WHO). is showing any indication of coagulation events caused by the vaccine.
At the beginning of Monday, Germany, France, Italy and Spain halted their jab deployments and Portugal, Luxembourg and Slovenia followed suit later in the day, while Latvia and Sweden continued on Tuesday morning. .
“Following new reports of cerebral venous thrombosis related to vaccinations in Germany and Europe, [Paul Ehrlich Institute] The PEI considers further investigation necessary, ”said German Health Minister Jens Spahn, who described the decision as” a pure precaution “.
The move by 13 countries in the bloc to stop the use of injections by the University of AstraZeneca / University of Oxford led the European drug watchdog, specifically the European Medicines Agency (EMA) to introduce the statement on Monday protects the vaccine deployment and announces an extraordinary meeting next Thursday evaluating all the information gathered.
“The overall number of thromboembolic events among vaccinated persons does not appear to be higher than those seen in the general population,” the EMA said in a statement released Tuesday.
Amsterdam-based company head Emer Cooke emphasized that “the benefits of the AstraZeneca vaccine in preventing COVID-19, with the associated risk of hospitalization and death, outweigh the risk of side effects” .
Speaking at a press conference, the EMA’s CEO expressed her concerns about the suspension of vaccines, arguing that they could “affect vaccine confidence … it is our duty to make sure the products we allow are safe. ”